ALLMedicine™ Essential Thrombocytosis Center
Research & Reviews 77 results
https://doi.org/10.1111/ijd.16162
International Journal of Dermatology; Amitay-Laish I, Solomon-Cohen E et. al.
Apr 11th, 2022 - Data on Demodex in the immunosuppressed state is limited, focusing mainly on patients with human immunodeficiency virus and hematological malignancies. The aim of this study was to describe the manifestations of facial demodicosis in diverse immun...
https://doi.org/10.1111/bjh.18165
British Journal of Haematology; Rabadan Moraes G, Pasquier F et. al.
Apr 1st, 2022 - Myeloproliferative neoplasms (MPN) are mainly sporadic but inherited variants have been associated with higher risk development. Here, we identified an EPOR variant (EPORP488S ) in a large family diagnosed with JAK2V617F -positive polycythaemia ve...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792018
Blood Cancer Journal; Pandey G, Kuykendall AT et. al.
Jan 28th, 2022 - The Philadelphia chromosome negative myeloproliferative neoplasms, including polycythemia vera, essential thrombocytosis, and myelofibrosis, are driven by hyper activation of the JAK2 tyrosine kinase, the result of mutations in three MPN driving g...
https://doi.org/10.1016/j.beha.2021.101330
Best Practice & Research. Clinical Haematology; Spivak JL
Dec 7th, 2021 - The myeloproliferative neoplasms (MPN), polycythemia vera (PV), essential thrombocytosis and primary myelofibrosis, are an unusual group of myeloid neoplasms, which arise in a pluripotent hematopoietic stem cell (HSC) due to gain of function drive...
https://clinicaltrials.gov/ct2/show/NCT02098161
Nov 10th, 2021 - PRIMARY OBJECTIVES: I. To determine the efficacy of LCL161 as therapy for primary myelofibrosis (PMF), post-polycythemia vera (PV) myelofibrosis (MF) and post-essential thrombocytosis (ET) MF. II. To determine the objective response which is defin...
Clinicaltrials.gov 3 results
https://clinicaltrials.gov/ct2/show/NCT02098161
Nov 10th, 2021 - PRIMARY OBJECTIVES: I. To determine the efficacy of LCL161 as therapy for primary myelofibrosis (PMF), post-polycythemia vera (PV) myelofibrosis (MF) and post-essential thrombocytosis (ET) MF. II. To determine the objective response which is defin...
https://clinicaltrials.gov/ct2/show/NCT03869476
Sep 12th, 2019 - The diagnostic criteria for myeloproliferative neoplasia have recently been revised in the WHO 2016 classification, which now recognizes a new entity between essential thrombocythemia (TE) and overt myelofibrosis (or primary myelofibrosis): prefib...
https://clinicaltrials.gov/ct2/show/NCT02862366
Oct 31st, 2018 - Patients with myeloproliferative neoplasms Philadelphia chromosome negative (MPNsPh1-) such as Essential thrombocytosis (ET), Polycythemia vera (PV) and Primary Myelofibrosis (PMF) have a higher risk of arterial or deep-vein thrombosis. This is re...
News 3 results
https://www.onclive.com/view/ong_5qs_with_charles_morris
Mar 15th, 2022 - 1 Why are self-survival and self-renewing pathways such promising areas of discovery at this time for Cephalon? If we can understand the methods and the pathways by which cells are able to either prolong their survival or sustain their own prolif...
https://www.mdedge.com/emergencymedicine/article/82551/hematology/case-report-headache-postpartum-patient-essential
Caleb P. Canders, MD, Taku Taira, MD
May 1st, 2014 - Case A 32-year-old woman, 4 weeks postpartum, presented to the ED with a chief complaint of headache, which she stated had become worse over the past 4 days. The headache was gradual-onset, bioccipital, and pressure-like.
https://www.mdedge.com/hematology-oncology/article/77462/leukemia-myelodysplasia-transplantation/c-albicans-appendicitis
Rohtesh S. Mehta, MD, MPH, MS, David Cohen, MD
Sep 4th, 2013 - A 62-year-old white man with a past medical history of hypertension and essential thrombocytosis diagnosed 17 years ago presented at our institution. He was being treated with hydroxyurea, with which he required occasional blood transfusions and p.
